Long-Term Efficacy and Safety of Infliximab in the Treatment of Behçet’s Disease

By Capella María José   Foster C. Stephen  

Ocular Immunology and Inflammation, Vol. 20, Iss. 3, 2012-06 ,pp. : 198-202

Informa Healthcare

Access to resources Recommend Favorite

Successful Treatment with Infliximab for Behçet Disease during Pregnancy

By Takayama Kei   Ishikawa Sho   Enoki Toshio   Kojima Teruo   Takeuchi Masaru  

Ocular Immunology and Inflammation, Vol. 21, Iss. 4, 2013-08 ,pp. : 321-323

Informa Healthcare

Access to resources Recommend Favorite

Long-term Clinical Outcomes in Patients with Refractory Uveitis Associated with Behçet Disease Treated with Infliximab

By Al Rashidi Sultan   Al Fawaz Abdullah   Kangave Dustan   Abu El-Asrar Ahmed M.  

Ocular Immunology and Inflammation, Vol. 21, Iss. 6, 2013-12 ,pp. : 468-474

Informa Healthcare

Access to resources Recommend Favorite

Rescue therapy: ciclosporin or infliximab?

By Rizzello Fernando   Praticò Chiara   Calabrese Carlo   Gionchetti Paolo  

Expert Review of Clinical Immunology, Vol. 9, Iss. 6, 2013-06 ,pp. : 503-505

Informa Healthcare

Access to resources Recommend Favorite

Phenotypic abnormalities of peripheral blood mononuclear cells in patients with Behçet’s disease and association with HLA-B51 expression

By Sakly K.   Lahmar R.   Nefzi F.   Hammami S.   Harzallah O.   Sakly N.   Sakly W.   Hassine M.   Mahjoub S.   Ghedira I.   Feki S.  

Immunological Investigations, Vol. 43, Iss. 5, 2014-07 ,pp. : 463-478

Informa Healthcare

Access to resources Recommend Favorite